Cargando…
Correlation of PD-L1 Expression with Clinicopathological and Genomic Features in Chinese Non-Small-Cell Lung Cancer
Programmed cell death 1 ligand 1 (PD-L1) has been approved as predictive biomarker for non-small-cell lung cancer (NSCLC) patients treated with PD-(L)1 blockade therapy. The clinical/genomic features associated with PD-L1 are not well studied. Genomic profiling of tumor biopsies from 883 Chinese NSC...
Autores principales: | Li, Yue, Li, Chong, Jiang, Ya, Han, Xue, Liu, Sisi, Xu, Xiuxiu, Tang, Wanxiangfu, Ou, Qiuxiang, Bao, Hua, Wu, Xue, Shao, Yang, Xing, Minyan, Zhang, Yixiang, Wang, Yuezhen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9015849/ https://www.ncbi.nlm.nih.gov/pubmed/35444698 http://dx.doi.org/10.1155/2022/1763778 |
Ejemplares similares
-
PD-L1 and PD-1 expression are correlated with distinctive clinicopathological features in papillary thyroid carcinoma
por: Bai, Yanhua, et al.
Publicado: (2017) -
The clinicopathological and prognostic features of Chinese and Japanese inpatients with lung cancer
por: Gao, Yang, et al.
Publicado: (2016) -
Incidental Prostate Cancer at the Time of Cystectomy: The Incidence and Clinicopathological Features in Chinese Patients
por: Pan, Jiahua, et al.
Publicado: (2014) -
Clinical and molecular characteristics of kinase domain duplications across diverse cancer types in the Chinese population
por: Lai, Xiaojing, et al.
Publicado: (2022) -
PD-L1 expression and its clinicopathological correlation in advanced esophageal squamous cell carcinoma in a Chinese population
por: Rong, Lulu, et al.
Publicado: (2019)